Assessing placental membrane treatment efficiency in diabetic foot ulcers: Processing for retention versus lamination

Jun 4, 2024
Zwelithini Tunyiswa, Robert G. Frykberg
Zwelithini Tunyiswa, Robert G. Frykberg
Assessing placental membrane treatment efficiency in diabetic foot ulcers: Processing for retention versus lamination

Diabetic foot ulcers are a severe complication in diabetic patients, significantly impact healthcare systems and patient quality of life, often leading to hospitalization and amputation.

Abstract

Background

Diabetic foot ulcers are a severe complication in diabetic patients, significantly impact healthcare systems and patient quality of life, often leading to hospitalization and amputation. Traditional Standard of Care (SOC) treatments are inadequate for many patients, necessitating advanced wound care products (AWCPs) like human placental membranes. This study conducts a retrospective analysis to compare the effectiveness of two human placental membrane products, retention-processed amnion chorion (RE-AC) and lamination-processed amnion chorion (L-AC) in managing chronic diabetic foot ulcers (DFUs).

Methods

The study collected retrospective observational data from electronic health records (EHRs) of patients treated for DFU at three outpatient wound care centers. Patients were categorized into two cohorts based on the treatment received. Key metrics included wound size progression and the number of product applications. The analysis employed Bayesian estimation, utilizing an analysis of covariance model with a Hurdle Gamma likelihood.

Results

We found that RE-AC achieved a marginally higher expected Percent Area Reduction (xPAR) in DFUs compared to L-AC at 12 weeks (67.3% vs. 52.6%). RE-AC also required fewer applications, suggesting greater efficiency in general wound closure. Probability of full wound closure was similar in both groups (0.738 vs 0.740 in RE-AC and L-AC, respectively).

Conclusion

The findings suggest that while L-AC might be slightly more effective in complete ulcer healing, RE-AC offers overall better treatment efficiency, especially in reducing the frequency of applications. This efficiency can lead to improved patient comfort, reduced treatment costs, and optimized resource utilization in healthcare settings.

READ ENTIRE ARTICLE: https://onlinelibrary.wiley.com/doi/10.1002/hsr2.2196

More Research

The Latest Research

Sep 30, 2024
Wendy W. Weston
Wendy W. Weston

Retention processed placental membrane versus standard of care in treating diabetic foot ulcers

Diabetic foot ulcers (DFUs) are a severe complication for diabetic patients, significantly impacting patient quality of life and healthcare system efficiency. Traditional standard of care (SOC) treatments are inadequate for many patients, necessitating the use of advanced wound care products, such as human placental membranes.

Sep 9, 2024
David G. Armstrong, Dennis P. Orgill, Robert D. Galiano, Paul M. Glat, Marissa J. Carter, Jason Hanft, Maria Surprenant, Adam L. Isaac, Charles M. Zelen
David G. Armstrong, Dennis P. Orgill, Robert D. Galiano, Paul M. Glat, Marissa J. Carter, Jason Hanft, Maria Surprenant, Adam L. Isaac, Charles M. Zelen

A multicentre clinical trial evaluating the outcomes of two application regimens of a unique keratin-based graft in the treatment of Wagner grade one non-healing diabetic foot ulcers

Diabetic foot complications that lead to lower extremity amputations pose a significant challenge to the entire global health system.